Variant report
Variant | nsv528282 |
---|---|
Chromosome Location | chr5:92024632-92040221 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:21)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:21 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr5:92031123-92031376 | HepG2 | liver: | n/a | n/a |
2 | CEBPB | chr5:92031190-92031381 | HepG2 | liver: | n/a | n/a |
3 | E2F4 | chr5:92026073-92026264 | MCF10A-Er-Src | breast: | n/a | n/a |
4 | FAM48A | chr5:92031465-92031517 | GM12878 | blood: | n/a | n/a |
5 | GATA3 | chr5:92033395-92033871 | SH-SY5Y | brain: | n/a | chr5:92033630-92033640 |
6 | GATA3 | chr5:92032854-92033222 | SK-N-SH | brain: | n/a | chr5:92033091-92033112 chr5:92033094-92033110 chr5:92033095-92033105 |
7 | HNF4A | chr5:92031174-92031358 | HepG2 | liver: | n/a | n/a |
8 | IRF1 | chr5:92029756-92029767 | K562 | blood: | n/a | n/a |
9 | MAFF | chr5:92027036-92027073 | HepG2 | liver: | n/a | n/a |
10 | MAFK | chr5:92026963-92027070 | HepG2 | liver: | n/a | chr5:92027021-92027035 |
11 | MAFK | chr5:92027053-92027107 | HepG2 | liver: | n/a | n/a |
12 | MAX | chr5:92027924-92028059 | NB4 | blood: | n/a | chr5:92027989-92027999 |
13 | MYC | chr5:92035128-92035140 | MCF10A-Er-Src | breast: | n/a | n/a |
14 | NFYA | chr5:92036162-92036329 | Hela-S3 | cervix: | n/a | n/a |
15 | POLR2A | chr5:92037211-92037268 | HUVEC | blood vessel: | n/a | n/a |
16 | POLR2A | chr5:92026588-92026819 | Gliobla | brain: | n/a | n/a |
17 | POLR2A | chr5:92032693-92032746 | MCF10A-Er-Src | breast: | n/a | n/a |
18 | STAT3 | chr5:92027013-92027213 | MCF10A-Er-Src | breast: | n/a | n/a |
19 | STAT3 | chr5:92037014-92037171 | MCF10A-Er-Src | breast: | n/a | n/a |
20 | STAT3 | chr5:92025014-92025214 | MCF10A-Er-Src | breast: | n/a | n/a |
21 | TCF7L2 | chr5:92031362-92031793 | PANC-1 | pancreas: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000249984 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7735987 | chr5:92024632-92024633 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs554869523 | chr5:92024652-92024653 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs199936530 | chr5:92024705-92024706 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs113097918 | chr5:92024715-92024716 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs573916375 | chr5:92024795-92024796 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs34206201 | chr5:92024800-92024801 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs536254714 | chr5:92024811-92024812 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs138491448 | chr5:92024851-92024852 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs576176671 | chr5:92024858-92024859 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs545187599 | chr5:92024883-92024884 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs114114515 | chr5:92024908-92024909 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs368418571 | chr5:92024994-92024995 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs191654511 | chr5:92024995-92024996 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs74806661 | chr5:92025017-92025018 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs561643830 | chr5:92025029-92025030 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs115376101 | chr5:92025066-92025067 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs76073350 | chr5:92025086-92025087 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs79670471 | chr5:92025087-92025088 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs373937123 | chr5:92025101-92025102 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs180875459 | chr5:92025112-92025113 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs552326271 | chr5:92025200-92025201 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs186570721 | chr5:92025222-92025223 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs201387509 | chr5:92025320-92025321 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs190326892 | chr5:92025327-92025328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs116772096 | chr5:92025354-92025355 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs532475678 | chr5:92025402-92025403 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs568349286 | chr5:92025403-92025404 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs370133160 | chr5:92025431-92025432 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs556086044 | chr5:92025470-92025471 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs143029307 | chr5:92025498-92025499 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs556179234 | chr5:92025591-92025592 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs576112643 | chr5:92025599-92025600 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs374292863 | chr5:92025668-92025669 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs538778941 | chr5:92025705-92025706 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs77837192 | chr5:92025761-92025762 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs146193016 | chr5:92025772-92025773 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs572706996 | chr5:92025786-92025787 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs182097312 | chr5:92025805-92025806 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs561418009 | chr5:92025816-92025817 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs541019577 | chr5:92025887-92025888 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs543424443 | chr5:92025970-92025971 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs186639181 | chr5:92025981-92025982 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs540867439 | chr5:92026001-92026002 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs147975430 | chr5:92026023-92026024 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs551950592 | chr5:92026048-92026049 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs13175613 | chr5:92026071-92026072 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs528226169 | chr5:92026093-92026094 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs548414127 | chr5:92026127-92026128 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs568005324 | chr5:92026128-92026129 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs200610672 | chr5:92026237-92026238 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Mental retardation | 19471318 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:92024200-92025800 | Enhancers | Liver | Liver |
2 | chr5:92024600-92025400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr5:92025800-92029800 | Weak transcription | Liver | Liver |
4 | chr5:92029800-92031000 | Enhancers | Liver | Liver |
5 | chr5:92031000-92031800 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
6 | chr5:92031000-92031800 | Flanking Active TSS | Liver | Liver |
7 | chr5:92031000-92032400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr5:92031000-92032600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
9 | chr5:92031200-92031600 | Enhancers | HepG2 | liver |
10 | chr5:92031400-92031800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
11 | chr5:92031800-92032400 | Enhancers | Liver | Liver |
12 | chr5:92032600-92033200 | Enhancers | Fetal Brain Female | brain |
13 | chr5:92038000-92038400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
14 | chr5:92038000-92040600 | Enhancers | Fetal Heart | heart |
15 | chr5:92038400-92039600 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
16 | chr5:92039400-92040400 | Enhancers | Muscle Satellite Cultured Cells | -- |
17 | chr5:92039600-92040400 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
18 | chr5:92039600-92041000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
19 | chr5:92039600-92041200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
20 | chr5:92039800-92040600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
21 | chr5:92039800-92040600 | Enhancers | Osteobl | bone |
22 | chr5:92040200-92040600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
23 | chr5:92040200-92041200 | Enhancers | NHDF-Ad | bronchial |